Latest Insider Transactions at Immunity Bio, Inc. (IBRX)
This section provides a real-time view of insider transactions for Immunity Bio, Inc. (IBRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ImmunityBio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ImmunityBio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 28
2021
|
Barry J. Simon Director |
SELL
Open market or private sale
|
Direct |
11,304
-0.36%
|
$226,080
$20.53 P/Share
|
|
Jan 28
2021
|
Barry J. Simon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,304
+0.35%
|
$22,608
$2.0 P/Share
|
|
Jan 27
2021
|
Barry J. Simon Director |
SELL
Open market or private sale
|
Direct |
36,626
-1.14%
|
$732,520
$20.61 P/Share
|
|
Jan 27
2021
|
Barry J. Simon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
36,626
+1.13%
|
$73,252
$2.0 P/Share
|
|
Jan 12
2021
|
Sonja Nelson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,364
-51.5%
|
$245,460
$15.0 P/Share
|
|
Jan 12
2021
|
Sonja Nelson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,364
+26.34%
|
$34,092
$3.07 P/Share
|
|
Jan 04
2021
|
Sonja Nelson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
39,271
-65.8%
|
$510,523
$13.62 P/Share
|
|
Jan 04
2021
|
Sonja Nelson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,729
+27.58%
|
$68,187
$3.07 P/Share
|
|
Dec 22
2020
|
Barry J. Simon Director |
SELL
Open market or private sale
|
Direct |
130,000
-3.94%
|
$2,340,000
$18.05 P/Share
|
|
Dec 22
2020
|
Barry J. Simon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
130,000
+3.79%
|
$260,000
$2.0 P/Share
|
|
Dec 10
2020
|
John C Thomas Director |
SELL
Open market or private sale
|
Direct |
42,592
-17.03%
|
$425,920
$10.83 P/Share
|